All our tests are developed, optimized and evaluated on the basis of agreements with recognized experts for each of the diseases. This approach aims to quickly propose innovative new products on the market with the support of technical and medical experts, as well as decision makers, and with clear evidence of its reliability and effectiveness (clinical trials, publications).
Omunis has a continuously strengthened network of partners and experts, while adapting gradually to the development of its products. This network includes, quite naturally, the original laboratory of its founders, but also many other academic and industrial partners, international institutions, as well as large charitable foundations involved in the fight against infectious diseases.